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ABSTRACT
Mammalian endogenous circadian rhythms are entrained to the envi-
ronmental day-night cycle by light exposure. Melatonin is involved in this
entrainment by signaling the day-night information to the endogenous circa-
dian pacemaker. Furthermore, melatonin is known to affect the circadian
rhythm of body temperature directly. A striking property of the endogenous
melatonin signal is its synthesis pattern, characterized by long-term elevated
melatonin levels throughout the night. In the present study, the influence of
prolonged treatment with the melatonin agonist S20098 during the activity
phase of free-running rats was examined. This was achieved by giving
S20098 in the food. The free-running body temperature and activity rhythms
were studied. The present study shows that enhancement of the melatonin
signal, using S20098, affected the free-running rhythm by gradual phase ad-
vances of the start of the activity phase, consequently causing an increase in
length of the activity phase. A well-known feature of circadian rhythms is its
time-dependent sensitivity for light. Light pulse exposure of an animal
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housed under continuous dark conditions can cause a phase shift of the circa-
dian pacemaker. Therefore, in a second experiment, the influence of melato-
nin receptor stimulation on the sensitivity of the pacemaker to light was ex-
amined by giving the melatonin agonist S20098 in the food during 1 day
prior to exposure to a 60-min light pulse of 0, 1.5, 15, or 150 lux given at
circadian time (CT) 14. S20098 pretreatment caused a diminished light-
pulse-induced phase shift when a light pulse of low light intensity (1.5 lux)
was given. S20098 treatment via the food was sufficient to exert chronobiotic
activity, and S20098 treatment resulting in prolonged overstimulation of mel-
atonin receptors is able to attenuate the effect of light on the circadian timing
system. (Chronobiology International, 18(5), 781–799, 2001)
Key Words: Activity; Body temperature; Free-running rhythm; Light pulse;
Phase shift; Rat; S20098.
INTRODUCTION
In mammals, clear circadian rhythms have been shown for many behavioral
and physiological processes, such as sleep-wake patterns, thermoregulation, car-
diovascular function, and many neuroendocrine processes (1). Circadian rhythms
in mammals are generated by endogenous oscillators located in the suprachias-
matic nuclei (SCN) of the hypothalamus (1,2). Under natural conditions, these
endogenous rhythms are entrained by the environmental light-dark (LD) cycle.
In mammals, the SCN receives direct photic information from the environment
via neuronal input from the retina (3–5). In addition, light can affect the circa-
dian output generated by the SCN according to a phase-response curve (PRC)
(6–8), while under conditions of continuous light or darkness, circadian rhythms
free run with an endogenous period that deviates from an exact 24h.
Among the rhythms under SCN control are the synthesis and secretion of
the pineal hormone melatonin. From the SCN, a multisynaptic pathway reaches
the pinealocytes, in which norepinephrine is released, which activates N-acetyl-
transferase and melatonin production (9). Melatonin synthesis and secretion is
elevated during the dark phase, while synthesis is suppressed during the light
phase (10,11).
The pineal gland in turn has been shown to play a role in the organization
of circadian rhythmicity. There is clear evidence that melatonin feeds back on
the SCN, thereby modulating SCN-generated rhythms. In vivo and in vitro stud-
ies have shown a phase-dependent inhibitory effect of melatonin on metabolic
and neuronal activity in the SCN (12–14). This effect seems to be mediated by
melatonin receptors located in the SCN (15,16). Melatonin can affect the circa-
dian output generated by the SCN according to a PRC (17,18). Melatonin admin-
istration during the second half of the subjective day causes phase advances,
while administration at the beginning of the subjective day causes small phase
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delays (8,18,19). Furthermore, a well-studied feature of melatonin is the acceler-
ating reentrainment effect after a phase shift of the environmental light-dark cy-
cle, when an exogenous melatonin injection coincides with the new dark onset
time (20). However, removal of the main endogenous melatonin source (pineal-
ectomy) also causes an acceleration of reentrainment after a phase shift of the
environmental light-dark cycle (21). Moreover, pinealectomized rodents show
disrupted circadian rhythms under continuous light conditions (22). These last
findings suggest that melatonin depletion causes enhancement of the influence
of the light-dark cycle on the pacemaker system. Therefore, we hypothesized
that melatonin receptor overstimulation might attenuate the effects of light on
the pacemaker system.
To achieve melatonin receptor stimulation, the melatonin receptor agonist
S20098 (Servier, Courbevoie, France) was used. S20098 has specific melatonin
agonist properties. It has high specific binding activity for melatonin binding
sites (23), and it phase shifts the circadian pacemaker of rodents according to a
PRC, as was shown for melatonin (17). Moreover, like melatonin, S20098 accel-
erates the reentrainment of rhythms of the rat after a phase shift of the light-dark
cycle (20).
The majority of studies concerning the role of the pineal gland or melatonin
in rhythmicity of behavior and physiology have been performed by removal of
the pineal gland (21,22), or by giving short melatonin pulses via daily bolus
injections (24–27). Although endogenous melatonin production is characterized
by long-term elevated levels throughout the night, little is known about the effect
of prolonged stimulation of melatonin receptors throughout the dark phase on
rhythmicity. To achieve prolonged and enhanced stimulation of melatonin recep-
tors and to avoid possible entraining effects of daily injections, the melatonin
agonist S20098 was added to the food. Since rats are nocturnal animals, most of
the food intake and consequent S20098 ingestion took place during the active
phase of the rat, corresponding to the phase during which endogenous melatonin
is elevated.
In summary, in the present study, the chronobiological consequences of
prolonged and enhanced melatonin receptor stimulation by the melatonin agonist
S20098 on free-running rhythmicity in rats were examined. Furthermore, the
hypothesis that melatonin receptor overstimulation might attenuate the effects of
light on the pacemaker system was investigated.
MATERIAL AND METHODS
Plasma Levels S20098
Prior to investigating the influence of prolonged S20098 treatment via the
food on circadian rhythmicity, the plasma levels of S20098 were measured. Eight
male Wistar rats were individually housed under light-dark 12h:12h (LD 12h:
12h) conditions. The animals had free access to food and water. Under halothane
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anesthesia, the animals were provided with a permanent jugular vein cannula
according to the method of Steffens (28), giving the opportunity to take blood
samples without disturbing the animals. After surgery, animals were allowed to
recover for 2 weeks. After recovery, standard laboratory chow was replaced by
food mixed with S20098 in two concentrations, 750 parts per million (ppm) or
1500 ppm. One day after food replacement, the blood-sampling procedure
started. Once a day, for a period of 11 days, a 0.6-ml blood sample was collected
from each animal. Only one sample per day was taken to prevent a change of
fluid and/or food intake because of sampling. Blood samples were taken in a
random order at circadian time (CT) 2, 6, 10, 14, 18, or 22 (CT12 is the start of
the dark phase). Food intake (g) was measured during 2h prior to taking a blood
sample. Plasma samples were obtained by centrifugation for 10 min at 2600g
and 4°C and stored at −20°C until S20098 was determined using high-perfor-
mance liquid chromatography (HPLC) with electrochemical detection (Servier,
Courbevoie, France).
Free-Running Rhythms in Body Temperature and Activity
We housed 12 male Wistar rats individually in Plexiglas cages (25 × 25 ×
37.5 cm). Food and water were available ad libitum. Under halothane anesthesia,
animals were provided with an intraperitoneally implanted transmitter for mea-
suring body temperature and general activity telemetrically (TA10TA-F40, Data
Sciences, St. Paul, MN). Signals from the transmitter were picked up by a re-
ceiver board underneath the cages, fed to a personal computer, and processed
with a specialized recording and analysis system (Dataquest IV, Data Sciences).
After surgery, the animals were allowed to recover for 2 weeks. Initially, the
animals were housed under LD 12h:12h conditions using dim red light (<1 lux)
during the dark phase and bright white light (<100 lux) during the light phase.
After 8 days, the LD 12h:12h condition was switched to continuous dim red light
(DD; <1 lux). After 16 days in the DD condition, half of the animals received
food containing 1500 ppm S20098 (n = 6). The other half of the animals (n = 6)
received control food. Treatment lasted for 13 days, and the animals had continu-
ous free access to the food.
Data sampling of activity and body temperature occurred at 5-min intervals.
For the calculation of the free-running rhythm characteristics, τ (period), α (ac-
tivity phase length), and ρ (resting phase length), the time of the activity, and
temperature rise and drop were used as reference phases. The times of the tem-
perature and activity rise and drop were calculated by determining the crossings
between a 2h running mean and a 24h running mean of the original data (updated
every 5 min). The time points at which the 2h running mean rose above and fell
below the 24h running mean were used as the estimates of the start and end,
respectively, of the activity or high-temperature phase. Using the start and end
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of the activity and high-temperature phases, τ, α, and ρ were determined (see
Fig. 1).
Light-Pulse-Induced Phase Delay
Two groups, one of 10 and one of 12 male Wistar rats, were individually
housed in Plexiglas cages (30 × 40 × 20 cm). Food and water were available ad
libitum. As in the previous experiment, body temperature and activity were mon-
itored telemetrically from intraperitoneally implanted transmitters. After implan-
tation of the transmitter, the animals were allowed to recover for 1 week under
LD 12h:12h. After this recovery period, animals were subjected to constant envi-
ronmental conditions with light intensity below 0.1 lux to provide free-running
rhythms for temperature and activity.
After 14 days of continuous darkness, the standard laboratory chow was
replaced by food mixed with 1500 ppm S20098 or control food. One day after
the food change, a 60-min light pulse with an intensity of 0, 1.5, 15, or 150 lux
was given at the animal-specific CT14. During the light pulse, the animal was
placed in its home cage under a light-protected cover containing the lamp that
provided the light pulse. After the light pulse was given, the animal was placed
in a clean cage, and the S20098-enriched food or control food was replaced by
Figure 1. Example of calculation method for τ, α, and ρ based on 2h running mean and 24h
running mean.
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standard lab chow. Free-running rhythms were recorded after the light pulse for
two successive weeks, after which animals received a new light pulse of different
intensity. This procedure was repeated seven times for the first group of 10 ani-
mals, and two times for the second group of 12 animals. Each animal received
light pulses of different light intensities in a random order. In the first group,
light pulses ranging from 1.5 to 150 lux were given; in the second group, light
pulses ranging from 0 to 1.5 lux were given. Each rat was exposed to each
different combination of S20098 treatment and light pulse intensity only once.
An overview of the number of rats exposed to each combination of treatment
and light pulse is shown in Table 1.
For calculation of the light-induced phase shifts, the time of the steep rise
in temperature at the beginning of the circadian activity period or the time of the
sharp drop in temperature was used as the reference phase. For calculation of
the time points of steep increase and drop of temperature, see the section on
free-running rhythms. Although both temperature and locomotor activity were
recorded, only body temperature was used for calculation of the phase shifts
because body temperature was more stable and less fragmentary than locomotor
activity. Moreover, the locomotor activity rhythm in general corresponds with
the body temperature rhythm (29).
The free-running rhythm recorded during the 10 days prior to the light
pulse was used to measure the baseline phase. The start of the high-temperature
phase on the light pulse day was calculated using linear regression over the base-
line period of 10 days and extrapolated to the day of the light pulse (prepulse
onset). After the light pulse, 4 days of recording were omitted to exclude possible
transients. Linear regression was performed over the next 10 days and extrapo-
lated to the light pulse day (postpulse onset). The difference between calculated
prepulse and postpulse onsets was defined as the induced phase shift (Fig. 2).
The animal-specific CT14 was determined in the same way as the prepulse
onset.
Only the onsets of the high-temperature phase were used because the onsets
were more stable than the offsets of the high-temperature phase.
Table 1. Overview of Rat Exposure
Treatment Light Intensity (Lux) Number of Rats
Control 0 6
Control 1.5 12
Control 15 10
Control 150 10
S20098 0 6
S20098 1.5 11
S20098 15 10
S20098 150 10
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Figure 2. Method for calculating the light-induced phase shift. Start of elevated body temperature
phase (closed circles) and end of elevated body temperature phase (open circles) are shown for 10
days prior to light pulse (days 36–45) and for 10 days after the light pulse plus 4 transient days
(days 50–59). Arrow 1 indicates extrapolated prepulse elevated temperature phase onset; arrow 2
indicates extrapolated postpulse elevated temperature phase onset. The difference between prepulse
and postpulse onset at the day the light pulse was given is the phase shift induced by the light
pulse. For a detailed description, see Material and Methods section.
Statistics
Free-Running Rhythms in Body Temperature and Activity
To determine the effect of treatment in time on the start and the end of the
activity phase or elevated body temperature phase, a repeated-measures analysis
of variance (ANOVA) was performed using the treatment (control or S20098)
and time (days) as factors. To determine an effect of treatment on any of the free-
running rhythm characteristics, an independent samples t test was performed.
Light-Pulse-Induced Phase Shift
To determine the effect of light intensity and treatment, a repeated measures
ANOVA was performed with light intensity (0, 1.5, 15, or 150 lux) and treatment
(control or S20098) as factors. To determine the effect of treatment per light
intensity, a simple factorial ANOVA was performed.
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RESULTS
The 24h profile of plasma levels S20098 in rats having free access to food
containing 750 or 1500 ppm S20098 is shown in Fig. 3a, and that for food intake
is depicted in Fig. 3b. Food intake was measured over the 2h prior to when the
blood sample was taken, which means that the food intake value at CT10, for
example, indicates the amount of food eaten between CT8 and CT10. A clear
increase in S20098 during the dark phase (CT12–CT0) is shown for both groups,
Figure 3. (a) Plasma S20098 levels and (b) food intake throughout the 24h LD cycle during
long-term S20098 treatment. Food intake values indicate the amount of food eaten during the 2h
prior to the blood sample being taken.
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Figure 4. Examples of actograms based on general activity of (a) a control-treated animal and
(b) an S20098-treated animal. Days 1–11, LD 12h:12h; days 12–27, continuous darkness; days
28–40, continuous darkness and control or S20098 (1500 ppm) treatment.
while the levels during the light phase are mainly below the detection level (de-
tection level = 5 ng/ml). Especially for the group treated with 1500 ppm S20098,
a clear relationship between food intake and plasma levels of S20098 is seen,
with peak values for both food intake and plasma levels of S20098 occurring at
CT14 and CT22.
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Figure 4 shows two examples of actograms of general activity of one con-
trol (Fig. 4a) and one animal treated with S20098 (1500 ppm) animal (Fig. 4b).
At day 11, LD 12h:12h conditions were switched to continuous darkness, which
was characterized by a clear free-running rhythm. At day 27, standard laboratory
chow was replaced by control food or food containing S20098.
Table 2 shows results for τ, α, and ρ based on data collected during the
last 7 days of the baseline free run and the last 7 days of the treatment free run.
Control-treated animals showed a significant increase in τ (independent samples
t test, P = .017) during the last 7 days of treatment compared to the last 7 days
of baseline as measured from the start of the activity phase. Furthermore, con-
trol-treated animals showed an increase in the resting phase ρ (independent sam-
ples t test, P = .006) and a decrease in the activity phase α (independent samples
t test, P = .046). Also, as measured at the start of the elevated body temperature
phase, control-treated animals show an increase in τ (independent samples t test,
P = .003) and an increase of the low body temperature phase length (independent
samples t test, P = .009), while the elevated body temperature phase length was
not changed significantly.
S20098-treated animals showed no change in τ either based on activity or
based on temperature data. No significant change was shown for ρ and α in the
activity data. However, in the temperature data, a significant increase of the ele-
vated body temperature phase length (independent samples t test, P = .047) and
a trend toward a decrease in the low body temperature phase length (not signifi-
cant) was shown for S20098-treated animals. The lengthening of the elevated
body temperature phase length appears to be due to an advanced start of the
elevated body temperature phase in the S20098-treated animals compared to con-
trols (Fig. 5). Repeated measures ANOVA revealed an interaction (Time × Treat-
Table 2. Mean Values ± Standard Error of Mean for τ, α, and ρ Based on Body Temperature
and Activity Data
Treatment Condition τ Start τ End α ρ
Body
temperature
Control Baseline 24.299 ± 0.052 24.413 ± 0.045 12.555 ± 0.147 11.744 ± 0.156
S20098 Baseline 24.391 ± 0.019 24.386 ± 0.041 12.307 ± 0.251 12.064 ± 0.249
Control Treatment 24.607 ± 0.068
a 24.488 ± 0.106 11.937 ± 0.323 12.551 ± 0.224
a
S20098 Treatment 24.390 ± 0.032 24.493 ± 0.087 13.081 ± 0.269
a 11.411 ± 0.331
Activity
Control Baseline 24.264 ± 0.037 24.385 ± 0.046 12.647 ± 0.065 11.618 ± 0.069
S20098 Baseline 24.384 ± 0.033 24.447 ± 0.046 12.720 ± 0.283 11.652 ± 0.271
Control Treatment 24.558 ± 0.106
a 24.462 ± 0.067 11.937 ± 0.336
a 12.525 ± 0.282
a
S20098 Treatment 24.400 ± 0.075 24.507 ± 0.092 13.356 ± 0.323 11.153 ± 0.406
τ was calculated according to both the start and the end of the elevated body temperature or
activity phase.
aSignificant differences (P < .05) between control and treatment condition.
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Figure 5. (a) Start and end of daily activity phase. Start of activity phase is shown by open
circles for controls and solid circles for S20098-treated animals. End of activity phase is shown
by open triangles for controls and by closed triangles for S20098-treated animals. (b) Start and
end of daily elevated body temperature phase.
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ment) effect both for the start of the activity phase (F8,72 = 2.35, P = .026) and
the start of the elevated body temperature phase length (F8,75 = 2.34, P = .027).
Figure 6 shows actograms based on activity and temperature data for a
control-treated animal (Figs. 6a, 6b) and an S20098-treated animal (Figs. 6c, 6d)
given a light pulse (1.5 lux) at CT14. Figures 6e and 6f show actograms for an
animal treated with S20098 (days 10–11) exposed to the light pulse procedure
without receiving a light pulse. The actograms based on temperature were
achieved by depicting a dot at each 15-min bout when the 2h running mean was
higher than the 24h running mean, while no dot was depicted when the 2h run-
ning mean was lower than the 24h running mean (see also Fig. 1).
In control-treated animals, a light pulse given at CT14 caused a significant
light-intensity-dependent increase in phase delay (repeated measures ANOVA,
F3,28 = 7.68, P = .001) (Fig. 7). The size of the phase delay gradually increased
with the intensity of the light pulse from about 0 min (0 lux), through 90 min (1.5
lux), 110 min (15 lux), to 135 min (150 lux). Also, in S20098-treated animals, a
light pulse given at CT14 caused a significant light-intensity-dependent increase
in phase delay (repeated measures ANOVA, F3,26 = 10.07, P = .0001), the phase
delay increasing from about 10 min (0 lux), through 45 min (1.5 lux), to 120
min for both 15 and 150 lux.
Although no difference in phase delay was found between control- and
S20098-treated animals, using no light pulse (0 lux) or a light pulse of relative
high intensity (i.e., 15 or 150 lux), a clear difference was found in the phase
delay under the low light intensity of 1.5 lux. For this low light intensity, S20098
significantly attenuated the phase delay from about 90 min in control-treated
animals to about 45 min in S20098-treated animals (F1,12 = 5.10, P = .036)
(Fig. 7).
DISCUSSION
The present results show that chronic S20098 treatment affected the free-
running temperature rhythm of the male Wistar rat by advancing the start of the
elevated body temperature phase, while the end of the elevated body temperature
phase was not affected. Consequently, the elevated body temperature phase (α)
increased, while the low body temperature phase (ρ) decreased.
The treatment method raises the question whether the route of administra-
tion was sufficient to exert chronobiotic activity. Therefore, the plasma S20098
levels during S20098 treatment via the food were measured. In comparison to
acute oral administration, the plasma levels of S20098, ranging from 11 to 35
ng/ml in the dark phase (Fig. 3) were in the chronobiotic dose-effect range for
S20098. That is, acute oral administration in the range of 2.5, 5, and 10 mg/kg
resulted in plasma S20098 concentrations of about 20, 62, and 164 ng/ml, respec-
tively (30). The present peak plasma concentrations correspond to acute oral
administration with doses between 2.5 and 5 mg/kg. Martinet et al. (30) have
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Figure 6. Example of actograms based on activity (a, c, e) and body temperature data (b, d, f)
of an animal exposed to a 1.5-lux light pulse and pretreatment with control food (a and b), an
animal exposed to a 1.5-lux light pulse and pretreatment with S20098 (c and d), and an animal
exposed to a control pulse 0 lux and pretreatment with S20098 (e and f). Arrows and * indicate
the day and time, respectively, at which the light pulse was given. Dashed line indicates the
prepulse linear regression line; the solid line indicates the postpulse linear regression line.
(continued)
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Figure 6. Continued.
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Figure 6. Continued.
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Figure 7. Light-induced phase delays plotted for different light intensities. A 60-min light pulse
of 0, 1.5, 15, or 150 lux was given at CT14. S20098-treated animals (solid circles) show a dimin-
ished phase delay after exposure to a 1.5-lux light pulse compared to control animals (open circles).
*Significant difference (P < .05) between S20098 and control.
reported a clear dose-dependent response from 2.5 to 10 mg/kg S20098 (oral
administration) with an ED50 of 5.7 mg/kg for true entrainment of free-running
rhythms in rats (30). Thus, since the nighttime plasma S20098 concentrations
were within the dose-effect range for entrainment properties of S20098, the route
of administration was sufficient to exert chronobiotic activity.
Indeed, this was shown in the present results by the gradual phase-advanc-
ing effect of S20098 of free-running rhythms. Besides an effect on phase, it
might be worthwhile to note that long-term S20098 treatment via the food (1500
ppm) did not affect the amplitude of activity (data not shown), but shows a small
decrease in nighttime temperature values (about 0.1°C) compared to control-
treated animals (data not shown).
Daily melatonin injections have been shown to cause also an increase in α
in hamsters housed under entrained short-day conditions (LD 9h:15h) (31). As
in the present study, this increase was caused by phase advances of the start of
the activity phase, while the end of the activity phase was not affected (31).
In summary, an enhancement of the melatonin signal using S20098 given
in the food was sufficient to exert chronobiotic activity. This is shown by the
gradual phase advances of the start of the elevated body temperature phase in
S20098-treated animals.
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Furthermore, in our second experiment, results showed a light-intensity-
dependent increment in phase delay when a 60-min light pulse was presented at
CT14. One day of pretreatment with the melatonin agonist S20098 caused a
decrease in the light-induced phase delay at low-intensity light pulses (1.5 lux).
Partly in accordance with this, Benloucif et al. (32) showed also a reduction in
the light-induced phase delay in mice by pretreatment with melatonin. However,
they only reported an effect of melatonin when light pulses of high light intensity
were presented. Furthermore, in agreement with the present findings is the study
performed by Deacon and Arendt (33), in which it was shown that melatonin is
able to counter light-induced phase delays in humans.
A possible explanation for the present findings may be that the S20098
treatment phase advances the free-running rhythm acutely; consequently, the
light pulse will be given at a time point that does not correspond to CT14. If this
is the case, a light pulse given at another time point than CT14 might induce a
smaller phase shift. However, this explanation can be excluded since the acto-
gram, showing the free-running rhythm of an animal that received S20098 and
no light pulse, did not show any phase advance. Moreover, both control- and
S20098-treated groups that received no light did not show a phase shift. In accor-
dance with this, our first experiment showed no acute phase advances, but rather
gradual phase advances of the start of the elevated body temperature phase, re-
sulting in a phase advance of about 1 h compared to control-treated animals over
a period of 9 days.
In summary, the present results indicate diminished light sensitivity of the
pacemaker system, shown by a diminished light-induced phase delay, at least
under low light intensity. To strengthen this indication, further research is re-
quired to complete a fully phase-response curve for low light intensity light
pulses.
In conclusion, S20098 treatment via the food is sufficient to exert chronobi-
otic activity, and S20098 treatment resulting in prolonged overstimulation of
melatonin receptors is able to attenuate the effect of light on the circadian timing
system.
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